DE9290035U1 - Pyridazinonessigsäuren - Google Patents

Pyridazinonessigsäuren

Info

Publication number
DE9290035U1
DE9290035U1 DE9290035U DE9290035U DE9290035U1 DE 9290035 U1 DE9290035 U1 DE 9290035U1 DE 9290035 U DE9290035 U DE 9290035U DE 9290035 U DE9290035 U DE 9290035U DE 9290035 U1 DE9290035 U1 DE 9290035U1
Authority
DE
Germany
Prior art keywords
acetic acids
pyridazinone acetic
pyridazinone
acids
acetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE9290035U
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE9290035U1 publication Critical patent/DE9290035U1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
DE9290035U 1991-03-28 1992-03-09 Pyridazinonessigsäuren Expired - Lifetime DE9290035U1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67691991A 1991-03-28 1991-03-28

Publications (1)

Publication Number Publication Date
DE9290035U1 true DE9290035U1 (de) 1993-11-18

Family

ID=24716565

Family Applications (1)

Application Number Title Priority Date Filing Date
DE9290035U Expired - Lifetime DE9290035U1 (de) 1991-03-28 1992-03-09 Pyridazinonessigsäuren

Country Status (19)

Country Link
EP (1) EP0582643A1 (de)
JP (1) JPH06500793A (de)
CN (1) CN1065269A (de)
AU (1) AU658887B2 (de)
BR (1) BR9205810A (de)
CA (1) CA2107104A1 (de)
CZ (1) CZ387092A3 (de)
DE (1) DE9290035U1 (de)
FI (1) FI934222A (de)
HU (1) HUT67836A (de)
IE (1) IE920979A1 (de)
IL (1) IL101325A0 (de)
MX (1) MX9201414A (de)
NZ (1) NZ242152A (de)
PT (1) PT100301A (de)
TW (1) TW207998B (de)
WO (1) WO1992017446A2 (de)
YU (1) YU30392A (de)
ZA (1) ZA922238B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE297902T1 (de) 2001-02-28 2005-07-15 Pfizer Prod Inc Sulfonyl-pyridazinon-derivate zur verwendung als aldose-reduktase-inhibitoren
SE0100873D0 (sv) * 2001-03-13 2001-03-13 Astrazeneca Ab Method of treatment
EP1491540B1 (de) 2001-03-30 2006-12-13 Pfizer Products Inc. Zwischenprodukten für die Herstellung von Pyridazinon Aldose Reductase Inhibitoren.
AU761191B2 (en) * 2001-05-24 2003-05-29 Pfizer Products Inc. Therapies for tissue damage resulting from ischemia
US7572910B2 (en) 2003-02-20 2009-08-11 Pfizer, Inc. Pyridazinone aldose reductase inhibitors
CN111617072B (zh) * 2019-02-27 2023-06-20 苏州凯祥生物科技有限公司 一种高尿酸血症药物组合物及用于治疗高尿酸血症的药物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0676391B2 (ja) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法
FR2647676A1 (fr) * 1989-06-05 1990-12-07 Union Pharma Scient Appl Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase

Also Published As

Publication number Publication date
CA2107104A1 (en) 1992-09-29
HUT67836A (en) 1995-05-29
CZ387092A3 (en) 1994-02-16
IE920979A1 (en) 1992-10-07
TW207998B (de) 1993-06-21
IL101325A0 (en) 1992-11-15
PT100301A (pt) 1993-06-30
WO1992017446A3 (en) 1992-11-26
JPH06500793A (ja) 1994-01-27
MX9201414A (es) 1992-10-01
NZ242152A (en) 1994-07-26
EP0582643A1 (de) 1994-02-16
AU658887B2 (en) 1995-05-04
FI934222A0 (fi) 1993-09-27
AU1779692A (en) 1992-11-02
YU30392A (sh) 1994-11-15
HU9302728D0 (en) 1993-12-28
ZA922238B (en) 1993-09-27
CN1065269A (zh) 1992-10-14
WO1992017446A2 (en) 1992-10-15
FI934222A (fi) 1993-09-27
BR9205810A (pt) 1994-06-28

Similar Documents

Publication Publication Date Title
BR9206443A (pt) Acidos imidazoil-alquenoicos.
AP9200447A0 (en) Acetic acid derivatives
DE69124516D1 (de) Katheter
NO922226D0 (no) 7-isoindolinyl-kinolon- og naftyridonkarboksylsyre-derivater
NO921840D0 (no) Substituerte karboksylsyrederivater
DE69133019T2 (de) Imidazolyl-alkencarbonsäuren
DE69207785D1 (de) Wärmekopf
DK152892D0 (da) Pyridazinonderivater
DE4293023T1 (de) Schnellanschluß-Aufnahme
NO920420L (no) 3-quinuklidin-derivater
BR9205810A (pt) Acidos piridazinona acéticos
DE59205221D1 (de) 1-Alkoxyhexatrien-2-carbonsäureester
DE69305714D1 (de) Abspaltbare Carbonsäuren
FI933588A0 (fi) (karboxyl)alkyloxyalkylderivat av cyklodextriner
MX9101098A (es) Acidos piridiltio o piridiloxi-alcanoicos
NO921530L (no) Farmasoeytisk forbindelse
NO921529L (no) Farmasoeytisk forbindelse
NO933446D0 (no) Pyridazinon-eddiksyrer
FI944482A0 (fi) Etikkahapon talteenotto
ITMI910513A0 (it) Nuovi acidi indazolici
IT9019539A1 (it) Acidi indazolici
NO920022D0 (no) Umettede hydroksyalkylkinolinsyrer
DK160091D0 (da) Multilynkobling
KR930009125U (ko) 접속구
KR920015591U (ko) Vtr